embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="justify" style="text-align:justify;">PARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical...
Full story
Read the full story at Business Insider ↗
Continue reading this story on Business Insider, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.